Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06544200
What this trial is testing

Intra-operative Air Leak Management After Minimally Invasive Lung Segmental Resection

Who this might be right for
Lung Cancer Stage ILung; NodeAir Leak From Lung
University Hospital Padova 104
Testing effectiveness (Phase 2)Study completedNCT00039507
What this trial is testing

Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03158129
What this trial is testing

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage I Lung Non-Small Cell Cancer AJCC v7Stage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 101
Not applicableStudy completedNCT03325907
What this trial is testing

Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility Trial

Who this might be right for
Lung Neoplasms
Shanghai Pulmonary Hospital, Shanghai, China 20
Not applicableNot Yet RecruitingNCT06854939
What this trial is testing

A Prospective Study Investigating the Relationship Between Minimal Residual Disease Detection, Monitoring Frequency, and Prognosis in Non-small Cell Lung Cancer Patients Eligible for Curative Treatment.

Who this might be right for
NSCLC, Stage I, II, III
National Cancer Center, Japan 350
Early research (Phase 1)Study completedNCT05479812
What this trial is testing

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Werewolf Therapeutics, Inc. 156
Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing

SCION: SABR and Checkpoint Inhibition of NSCLC

Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT00062270
What this trial is testing

Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Ended earlyNCT03050554
What this trial is testing

SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Andrew Sharabi 2
Testing effectiveness (Phase 2)Study completedNCT01240720
What this trial is testing

A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer

Who this might be right for
Cancer
Philogen S.p.A. 65
Testing effectiveness (Phase 2)Ended earlyNCT01455389
What this trial is testing

TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer

Who this might be right for
Lung Cancer
Genprex, Inc. 25
Testing effectiveness (Phase 2)Looking for participantsNCT07120282
What this trial is testing

Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 108
Not applicableUnknownNCT01920789
What this trial is testing

Stereotactic Precision And Conventional Radiotherapy Evaluation

Who this might be right for
Non-small Cell Lung Cancer
Ass. Prof. Jan Nyman 102
Testing effectiveness (Phase 2)Study completedNCT00002624
What this trial is testing

Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 66
Testing effectiveness (Phase 2)Study completedNCT01733589
What this trial is testing

Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC

Who this might be right for
Stage III Non-small-Cell Lung Cancer
Zhejiang Cancer Hospital 73
Not applicableUnknownNCT05921474
What this trial is testing

Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors

Who this might be right for
Non Small Cell Lung Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 100
Not applicableLooking for participantsNCT05502523
What this trial is testing

The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8+1 more
Thomas Jefferson University 100
Early research (Phase 1)UnknownNCT04397926
What this trial is testing

Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Sun Yat-sen University 20
Early research (Phase 1)Study completedNCT00019435
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+4 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00004225
What this trial is testing

Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Next Page